These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21016211)

  • 1. Present day conception of protamine zinc insulin and globin insulin with zinc; special references to insulin hypoglycemia and insulin mixtures.
    SINDONI A
    Del State Med J; 1946 Feb; 18():21-32. PubMed ID: 21016211
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the clinical use of protamine zinc insulin and globin insulin in equal doses.
    ROBERTS JT; YATER WM
    Ann Intern Med; 1947 Jan; 26(1):41-66. PubMed ID: 20278462
    [No Abstract]   [Full Text] [Related]  

  • 3. A nomogram for the preparation of insulin-protamine zinc insulin mixtures.
    ABRAHANSON EM
    Am J Dig Dis; 1945 Dec; 12():385-7. PubMed ID: 21007045
    [No Abstract]   [Full Text] [Related]  

  • 4. Protamine insulin mixtures in the treatment of diabetes mellitus.
    COLWELL AR
    N Y State J Med; 1947 May; 47(10):1103-10. PubMed ID: 20239260
    [No Abstract]   [Full Text] [Related]  

  • 5. Fasting blood sugar vs. postprandial blood sugar as observed in normal individuals, medical (non-diabetic) patients, and patients with diabetes; special references to; plain, protamine zinc and globin insulins, compatible hyperglycemia and arteriosclerosis.
    SINDONI A
    Am J Dig Dis; 1946 Jun; 13():178-92. PubMed ID: 20989656
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of globin insulin and protamine zinc insulin on the diurnal blood sugar curve and the daily glycosuria of diabetics, and the clinical use of globin insulin.
    ROBERTS JT
    Fed Proc; 1948 Mar; 7(1 Pt 1):251. PubMed ID: 18934428
    [No Abstract]   [Full Text] [Related]  

  • 7. DETERMINATION OF ZINC IN INSULIN PREPARATIONS.
    ZAK B; COHEN JS
    J Pharm Sci; 1963 Sep; 52():912-4. PubMed ID: 14061060
    [No Abstract]   [Full Text] [Related]  

  • 8. Insulin and insulin mixtures; nph insulin.
    BURNHAM DK
    Calif Med; 1951 Dec; 75(6):412-5. PubMed ID: 14886746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [INSULIN THERAPY OF DIABETES MELLITUS].
    KATSUKI S; HIRATA Y
    Naika; 1964 Apr; 13():709-15. PubMed ID: 14151351
    [No Abstract]   [Full Text] [Related]  

  • 10. Biphasic insulin aspart 30: literature review of adverse events associated with treatment.
    Davidson J; Vexiau P; Cucinotta D; Vaz J; Kawamori R
    Clin Ther; 2005; 27 Suppl B():S75-88. PubMed ID: 16519039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoglycaemic coma due to accidental intravenous administration of protamine zinc insulin.
    ADAMS DJ
    Med J Aust; 1946 Sep; 2(12):415. PubMed ID: 21001739
    [No Abstract]   [Full Text] [Related]  

  • 12. Lower rates of hypoglycemia during maintenance treatment with insulin degludec/insulin aspart versus biphasic insulin aspart 30: a combined analysis of two Phase 3a studies in type 2 diabetes.
    Christiansen JS; Niskanen L; Rasmussen S; Johansen T; Fulcher G
    J Diabetes; 2016 Sep; 8(5):720-8. PubMed ID: 26612062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical effectiveness of biphasic insulin aspart 30:70 versus biphasic human insulin 30 in UK general clinical practice: a retrospective database study.
    Morgan CL; Evans M; Toft AD; Jenkins-Jones S; Poole CD; Currie CJ
    Clin Ther; 2011 Jan; 33(1):27-35. PubMed ID: 21397771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of biphasic insulin aspart in patients with type 2 diabetes.
    Halimi S; Raskin P; Liebl A; Kawamori R; Fulcher G; Yan G
    Clin Ther; 2005; 27 Suppl B():S57-74. PubMed ID: 16519038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [On the therapeutic use of insulins with delayed action of "intermediary" duration: evaluation of a human globin insulin].
    DI MARCO G
    Praxis; 1962 May; 51():469-71. PubMed ID: 13886021
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk for nocturnal hypoglycemia with biphasic insulin aspart 30 compared with biphasic human insulin 30 in adults with type 2 diabetes mellitus: a meta-analysis.
    Davidson JA; Liebl A; Christiansen JS; Fulcher G; Ligthelm RJ; Brown P; Gylvin T; Kawamori R
    Clin Ther; 2009 Aug; 31(8):1641-51. PubMed ID: 19808125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and effectiveness of biphasic insulin aspart 30 in people with type 2 diabetes switching from basal-bolus insulin regimens in the A1chieve study.
    Dieuzeide G; Chuang LM; Almaghamsi A; Zilov A; Chen JW; Lavalle-González FJ
    Prim Care Diabetes; 2014 Jul; 8(2):111-7. PubMed ID: 23953707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EFFECTS OF PROTAMINE ZINC INSULIN ON CHICKENS.
    LEPKOVSKY S; LEN R; KOIKE T; BOUTHILET R
    Am J Physiol; 1965 Mar; 208():589-92. PubMed ID: 14264754
    [No Abstract]   [Full Text] [Related]  

  • 19. Insulin lispro 25/75 and insulin lispro 50/50 as starter insulin in Japanese patients with type 2 diabetes: subanalysis of the CLASSIFY randomized trial.
    Watada H; Imori M; Li P; Iwamoto N
    Endocr J; 2017 Jul; 64(7):705-717. PubMed ID: 28539526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin mixtures and modifications.
    PECK FB
    Med Clin North Am; 1947 Mar; 31():343-57. PubMed ID: 20293076
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.